|
Author, year | Study design | Sample size | Participants | Intervention | Main Outcomes |
Average age (years) | Gender (male/female) | Treatment group | Control group | Course (days) |
|
Dong et al., 2020 [36] | RCT | 90 | T: 51.4 ± 9.4; C: 52.6 ± 7.7 | T: 25/20; C: 27/18 | Manual acupuncture Flunarizine hydrochloride | Flunarizine hydrochloride | 21 | ①②③④⑦ |
Li et al., 2020 [37] | RCT | 80 | T: 61.53 ± 4.53; C: 62.13 ± 4.57 | T: 22/18; C: 21/19 | Manual acupuncture Conventional treatment | Conventional treatment | 20 | ⑥⑧ |
Zhang et al., 2020 [38] | RCT | 60 | — | — | Manual acupuncture Conventional treatment | Flunarizine hydrochloride Conventional treatment | 10 | ①②③④⑤ |
Deng et al., 2019 [39] | RCT | 60 | T: 62.17 ± 9.76; C:62.1 ± 10.17 | T: 11/19; C: 12/18 | Manual acupuncture Conventional treatment | Conventional treatment | 10 | ①⑤⑧ |
Dang, 2018 [40] | RCT | 69 | T:62.26 ± 20.23; C: 61.78 ± 21.57 | T: 14/25; C: 11/19 | Manual acupuncture Flunarizine hydrochloride Betastatin | Flunarizine hydrochloride Betastatin | 10 | ①⑦ |
Zhang et al., 2017 [41] | RCT | 60 | T: 62.40 ± 9.7; C: 61.30 ± 10.1 | T: 11/19; C: 10/20 | Manual acupuncture Conventional treatment | Flunarizine hydrochloride Conventional treatment | 7 | ①②③④ |
Zhou et al., 2017 [42] | RCT | 60 | T: 57.9 ± 12.8; C: 60.4 ± 12.7 | T: 23/17; C: 11/9 | Manual acupuncture Conventional treatment | Vinpocetine injection Conventional treatment | 14 | ① |
Chai, 2016 [43] | RCT | 92 | T: 56.7 ± 6.1; C: 57.3 ± 6.9 | T: 27/19; C: 25/21 | Manual acupuncture Flunarizine hydrochloride Conventional treatment | Flunarizine hydrochloride Conventional treatment | 20 | ①②③④⑤⑦ |
Chen et al., 2016 [44] | RCT | 70 | All: 49.3 ± 6.5 | T: 19/16; C: 17/18 | Electroacupuncture Conventional treatment | Conventional treatment | 14 | ① |
Geng, 2016 [45] | RCT | 70 | T: 59.3; C: 61 | T: 20/15; C: 17/18 | Manual acupuncture Betastatin Danhong injection | Betastatin Danhong injection | 14 | ①②③④ |
Zhang et al., 2014 [46] | RCT | 78 | T: 56.86; C: 57.02 | T: 17/22; C: 15/24 | Electroacupuncture Conventional treatment | Flunarizine hydrochloride Conventional treatment | 10 | ①②③④ |
Zhou et al., 2014 [47] | RCT | 60 | All: 54.0 ± 3.8 | T: 18/17; C: 15/10 | Manual acupuncture Pushen capsule | Pushen capsule | 15 | ① |
Cheng et al., 2013 [48] | RCT | 72 | T: 51.81 ± 5.63; C: 52.17 ± 6.07 | T: 13/22; C: 12/25 | Manual acupuncture Conventional treatment | Nimodipine Conventional treatment | 20 | ①⑤ |
Qian et al., 2013 [49] | RCT | 98 | T: 55.74 ± 5.36; C: 58.63 ± 5.75 | T: 26/23; C: 24/25 | Manual acupuncture Conventional treatment | Conventional treatment | 14 | ①②③④ |
Wang, 2013 [50] | RCT | 80 | T: 45–75; C: 48–77 | T: 23/17; C: 20/20 | Manual acupuncture Alprostadil injection | Alprostadil injection | 14 | ① |
Li et al., 2012 [51] | RCT | 112 | T: 60.2 ± 8.2; C: 59.1 ± 7.2 | T: 29/30; C: 26/27 | Manual acupuncture Conventional treatment | Conventional treatment | 20 | ① |
Liu et al., 2012 [52] | RCT | 71 | T: 60.46 ± 8.47; C: 59.83 ± 9.36 | T: 18/19; C: 14/20 | Electroacupuncture | Flunarizine hydrochloride | 42 | ①②③④ |
Ma and Zhang, 2012 [53] | RCT | 120 | T: 60.0 ± 3.4; C: 62.0 ± 2.8 | T: 21/39; C: 18/42 | Manual acupuncture Gastrodin injection Conventional treatment | Gastrodin injection Conventional treatment | 10 | ①②③④ |
Luo, 2010 [54] | RCT | 61 | T: 63.74 ± 16.75; C: 62.98 ± 19.42 | T: 20/11; C: 18/12 | Manual acupuncture Conventional treatment | Conventional treatment | 18 | ① |
Gao and Zhao, 2009 [55] | RCT | 78 | T: 60.49 ± 4.87; C: 59.89 ± 5.06 | T: 24/18; C: 20/16 | Manual acupuncture Conventional treatment | Flunarizine hydrochloride Conventional treatment | 15 | ① |
|